We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Potential Biologic Warfare Agent Disables Neutrophil Response

By Biotechdaily staff writers
Posted on 28 Dec 2006
Researchers have learned how the causative agent of tularemia, Francisella tularensis, infects and survives in blood cells that normally destroy invading bacteria. While F tularensis rarely infects people, its potential to be used as a bio-terrorist tool has generated increased interest in understanding its life cycle.

Investigators at the University of Iowa (Iowa City, USA) were primarily interested in finding out why despite being able to ingest F tularensis, human blood neutrophils were unable to kill them.

Results published in the December 2006 issue of the Journal of Leukocyte Biology demonstrated that the bacteria's ability to disrupt the neutrophils' "respiratory burst” was largely responsible for their ability to survive. This evidence was provided by luminol-enhanced chemiluminescence and nitroblue tetrazolium staining, which showed that neutrophils infected with live F tularensis did not generate reactive oxygen species.

"We wanted to better understand how Francisella tularensis could overcome the body's innate immune response and cause disease. In addition, learning more about this bacterium can help us learn more about the overall human immune response to bacteria,” explained senior author Dr. Lee-Ann Allen, associate professor of internal medicine and microbiology at the University of Iowa. "The rate of tularemia infection has significantly declined since the 1940s. However, the bacteria would be very deadly as an aerosolized terrorist weapon--inhaling as few as 10 bacteria could be potentially deadly.”



Related Links:
University of Iowa

New
Gold Member
Aspiration System
VACUSAFE
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Steam Sterilizer
Hi Vac II Line
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
28 Dec 2006  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
28 Dec 2006  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
28 Dec 2006  |   BioResearch